Fever of unknown origin (FUO) due to efalizumab, an immunomodulating agent.
Pherez
F M
FM
Cunha
B A
BA
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001772:Blood Cell Count; D001792:Blood Platelets / Q000166:cytology; D005335:Fever of Unknown Origin / Q000139:chemically induced* / Q000175:diagnosis* / Q000276:immunology; D006801:Humans; D008214:Lymphocytes / Q000166:cytology; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab